Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M2,132Revenue $M231Net Margin (%)-35.2Altman Z-Score-1.8
Enterprise Value $M2,066EPS $-0.6Operating Margin %-12.7Piotroski F-Score3
P/E(ttm)--Beneish M-Score1.1Pre-tax Margin (%)-35.0Higher ROA y-yN
Price/Book32710-y EBITDA Growth Rate %--Quick Ratio5.5Cash flow > EarningsY
Price/Sales9.15-y EBITDA Growth Rate %-19.4Current Ratio5.7Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-17.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-209.0Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M136ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with NKTR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
NKTRJoel Greenblatt 2015-09-30 Sold Out -0.14%$9.5 - $13.92
($11.79)
$ 15.6833%Sold Out0
NKTRJoel Greenblatt 2015-06-30 Buy 0.14%$9.52 - $13.84
($11.47)
$ 15.6837%New holding1,363,927
NKTRFirst Eagle Investment 2011-12-31 Sold Out -0.003%$4.22 - $5.62
($4.92)
$ 15.68219%Sold Out0
NKTRFirst Eagle Investment 2011-09-30 Buy $4.98 - $7.65
($5.97)
$ 15.68163%New holding125,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

NKTR is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


NKTR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Lingnau LutzDirector 2016-04-25Sell15,000$16.27-3.63view
Thomsen Jillian B.SVP & Chief Accounting Officer 2016-03-09Sell15,000$11.7932.99view
Gergel Ivan P.SVP & Chief Medical Officer 2016-02-17Sell556$11.9231.54view
Nicholson JohnSVP & CFO 2016-02-17Sell963$11.9231.54view
ROBIN HOWARD WPresident & CEO 2016-02-17Sell2,147$11.9231.54view
Doberstein Stephen KSVP & Chief Scientific Officer 2016-02-17Sell390$11.9231.54view
Thomsen Jillian B.SVP & Chief Accounting Officer 2016-02-17Sell716$11.9231.54view
Labrucherie Gil MSVP & General Counsel 2016-02-17Sell827$11.9231.54view
Hora ManinderSVP Pharma Dev & Mfg Ops 2016-02-17Sell963$11.9231.54view
ROBIN HOWARD WPresident & CEO 2016-02-10Sell66,666$11.4936.47view

Quarterly/Annual Reports about NKTR:

News about NKTR:

Articles On GuruFocus.com
Weekly CEO Sales Highlight: Monolithic Power Systems, Five Prime Therapeutics, Nektar Therapeutics Feb 15 2016 
Weekly CEO Sells Highlight: Cadence Design Systems Inc., Nektar Therapeutics Inc., Netflix Inc., Pho Sep 27 2015 
Weekly Guru Bargains Highlights: AKAM, NKTR, LOGI, FFIV, LCC Apr 16 2011 
Weekly Guru Bargains Highlights: AMSC, LOGI, NKTR, DAL, AIG Apr 09 2011 
Four Guru Stocks near New Lows: FBN, HOME, NKTR, PETS Feb 07 2011 
MannKind: Deja Vu for the FDA and Afrezza Dec 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Nov 04 2010 
Nektar Therapeutics Reports Operating Results (10-Q) Jul 29 2010 
Nektar Therapeutics Reports Operating Results (10-Q) May 06 2010 
Small-Cap Biotech Stocks: Why This Sector Is Set for a Huge Year Jan 06 2010 

More From Other Websites
Nektar to Announce Financial Results for the First Quarter 2016 on Tuesday, May 3, 2016, After Close... Apr 28 2016
Nektar to Announce Financial Results for the First Quarter 2016 on Tuesday, May 3, 2016, After Close... Apr 28 2016
Nektar Therapeutics Presents Pre-Clinical Data Combining NKTR 214 With Checkpoint Blockade Apr 18 2016
Preclinical Data Presented at AACR Demonstrate that Combining NKTR-214 with Checkpoint Blockade is... Apr 18 2016
Preclinical Data Presented at AACR Demonstrate that Combining NKTR-214 with Checkpoint Blockade is... Apr 18 2016
Why You Shouldn't Bet Against Nektar Therapeutics (NKTR) Stock Mar 17 2016
Nektar Therapeutics breached its 50 day moving average in a Bearish Manner : NKTR-US : March 17,... Mar 17 2016
ETF’s with exposure to Nektar Therapeutics : March 14, 2016 Mar 14 2016
Nektar Therapeutics :NKTR-US: Earnings Analysis: Q4, 2015 By the Numbers Mar 14 2016
NEKTAR THERAPEUTICS Financials Mar 05 2016
Nektar Therapeutics to Present at Cowen and Company's 36th Annual Health Care Conference in Boston,... Mar 03 2016
Nektar Therapeutics (NKTR) Stock Slumps Despite Q4 Beat Mar 02 2016
Nektar (NKTR) Reports Narrower-than-Expected Q4 Loss Mar 02 2016
Edited Transcript of NKTR earnings conference call or presentation 1-Mar-16 10:00pm GMT Mar 02 2016
NEKTAR THERAPEUTICS Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Mar 01 2016
Nektar Therapeutics Earnings Call scheduled for 5:00 pm ET today Mar 01 2016
Nektar reports 4Q loss Mar 01 2016
Nektar reports 4Q loss Mar 01 2016
Nektar Therapeutics Reports Fourth Quarter and Year-End 2015 Financial Results Mar 01 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)